Macmillan invests in Lucida Medical’s AI prostate cancer diagnostic aid
[ad_1] Macmillan Cancer Support is investing £350,100 in Lucida Medical’s new AI platform, Pi, with the aim of improving the speed and accuracy of prostate cancer tests. This could help to improve…